2026.05.11
NewsMay 11, 2026
Home Run Biotech has achieved remarkable success at the 29th Moscow International Salon of Inventions and Innovative Technologies "Archimedes" in 2026. Its flagship research achievement, "Ginkgo-Cultivated Cordyceps Militaris Dropping Pills," was honored with a Gold Medal, garnering high praise from the assembly’s organizing committee.
The "Moscow Archimedes Exhibition" is officially recognized as a "Prominent International Invention Exhibition" by the Intellectual Property Office of the Ministry of Economic Affairs (TIPO), holding significant international prestige. This year's exhibition was grand in scale, featuring over 500 innovative invention projects from more than 24 countries competing for honors.
Home Run Biotech's research and development technology demonstrated world-class competitiveness, standing out during a rigorous evaluation process. By successfully transforming scientific research into high-quality health products, the company continues to uphold its spirit of innovation. Home Run Biotech remains dedicated to deep cultivation within the field of preventive medicine and is committed to promoting Taiwan's biotechnological achievements to the global market.
